prostate cancer

Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tue, 05/22/12 - 11:16 am
Medivation
Astellas
prostate cancer
Enzalutamide
What You Must Know Before Investing in Prostate Cancer Stocks
Minyanville
Mon, 05/21/12 - 12:22 pm
prostate cancer
Dendreon
Cougar Biotechnology
JNJ
Medivation
Exelixis
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say
Xconomy
Thu, 05/17/12 - 10:28 am
PSA
prostate cancer
Dendreon
J&J’s Zytiga Helps Eliminate Early-Stage Prostate Cancer
Bloomberg
Thu, 05/17/12 - 10:16 am
JNJ
Zytiga
prostate cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel
Sat, 05/5/12 - 05:30 pm
OPKO Health
contract
International Health Technology
cancer
prostate cancer
FDA rejects Amgen's application for Xgeva
Reuters
Fri, 04/27/12 - 10:31 am
FDA
Amgen
prostate cancer
Xgeva
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Fri, 04/13/12 - 08:29 am
Dendreon
Provenge
JNJ
Medivation
prostate cancer
Immunogen
Seattle Genetics
Dendreon: Healthy Competition Will Boost Profits
Seeking Alpha
Tue, 04/10/12 - 11:15 am
Dendreon
Provenge
prostate cancer
Abbott Laboratories
Bristol-Myers Squibb
JNJ
Sanofi
Provenge And The Immunodepletion Theory: The Facts
Seeking Alpha
Mon, 04/9/12 - 01:08 pm
Provenge
Dendreon
immunodepletion
prostate cancer
Peregrine provides additional Bavituxima preclinical prostate cancer data
Yahoo/Fly on the Wall
Wed, 04/4/12 - 09:39 am
Peregrine Pharmaceuticals
bavituximab
prostate cancer
Buy, Sell, or Hold: Exelixis
Motley Fool
Sat, 03/24/12 - 11:38 am
cabozantinib
prostate cancer
Exelixis
Are Takeover Talk and Provenge Adding Optimism to Dendreon’s Biggest Institutional Shareholders?
Wall St. Cheat Sheet
Fri, 03/23/12 - 11:29 am
Provenge
prostate cancer
Dendreon
M&A
[video]The Drama's Not Over at Dendreon
Motley Fool
Thu, 03/15/12 - 09:20 am
Dendreon
prostate cancer
Provenge
Dendreon does not see choice between Provenge and Jevtana/Zytiga as 'either/or'
Yahoo/Fly on the Wall
Wed, 03/14/12 - 10:45 am
Dendreon
Provenge
Jevtana
Zytiga
prostate cancer
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sun, 03/11/12 - 12:12 pm
Zytiga
Provenge
prostate cancer
JNJ
Dendreon
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up
Xconomy
Fri, 03/9/12 - 10:47 am
prostate cancer
OncoGenex
custirsen
Bellicum snags $20M for mid-stage cancer vaccine program
Fierce Biotech
Thu, 03/8/12 - 03:33 pm
BPX-101
prostate cancer
Bellicum
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Mon, 03/5/12 - 11:13 am
Dendreon
Provenge
prostate cancer
Celldex
Agenus
Cel-Sci
ImmunoCellular

Pages